Genmab to Host Post ASH Seminar
Genmab hosted a webcast focused on the latest developments in antibody innovation on December 10, 2013. The seminar included discussion of data from studies of ofatumumab and daratumumab presented at the 2013 Annual Meeting of the American Society of Hematology (ASH), Genmab's proprietary antibody technologies and expected performance milestones for 2014. Click here to view the slides. Click here to view a replay of the webcast.
Genmab published its Third Quarter 2013 financial results and held a conference call on November 6. Click the following links to access the archived call: Listen to the webcast/podcast; download the podcast; download the slide presentation.
Explore our Download library to access presentations given at investor and scientific conferences, financial reports, images, podcasts and more.